Search Results for Direct-to-Consumer

Showing 1 – 10

DTC Drug Ads: New Study Finds Perception of Risks Diluted by Lengthy Side Effects List By Michael Mezher - Published 11 October 2017

A study on direct-to-consumer (DTC) drug advertising published Monday in Nature Human Behavior finds that consumers perceive drugs to be less risky when ads for the drug list all of its side effects compared to when only serious side effects are listed.

Categories: News, US, FDA, Advertising and Promotion, Drugs

Tags: Direct-to-Consumer, Drug Advertising, Side Effects, Risk

FDA Officials Study Alternative Approach to Presenting Risk Info in TV Drug Ads By Michael Mezher - Published 07 August 2017

A recent study by US Food and Drug Administration (FDA) officials and research firm RTI International suggests that an alternative approach to presenting limited risk information in direct-to-consumer (DTC) TV drug advertising may improve consumers' ability to recall those risks.

Categories: News, US, FDA, Advertising and Promotion, Drugs

Tags: Direct-to-Consumer, DTC, Drug Advertising, Risk, Fair Balance

DTC Drug Advertising: FDA to Launch First Public Survey Since 2002 By Zachary Brennan - Published 26 February 2016

Direct-to-consumer (DTC) advertising for pharmaceuticals has been a hot topic recently as federal and state officials have questioned their utility, particularly as the US and New Zealand are the only two countries in the world that have them. Now, the US Food and Drug Administration (FDA) is looking to survey patients about their experiences with DTC drug ads.

Categories: News, US, FDA, Advertising and Promotion, Biologics and biotechnology, Drugs, Regulatory strategy, Research and development

Tags: DTC pharmaceutical advertising, direct-to-consumer advertising, pharmaceutical ads, drug ads

FDA Warns Three Companies Over DTC Genetic Tests By Michael Mezher - Published 09 November 2015

Last week, the US Food and Drug Administration (FDA) sent letters to three genetic testing companies for marketing unapproved direct-to-consumer (DTC) tests.

Categories: News, US, CDRH, Compliance, In vitro diagnostics, Medical Devices

Tags: Direct-to-consumer, DTC, Genetic tests, Laboratory Developed Tests, LDT, LDTs, DNA4Life, DNA-CardioCheck, Interleukin Genetics

What Did You Say? FDA Plans Study on How Hearing Loss Affects Drug Ad Understanding By Alexander Gaffney, RAC - Published 24 June 2015

The US Food and Drug Administration (FDA) says it is planning a new study to assess whether older Americans are able to adequately hear all of the risks presented in televised pharmaceutical advertising.

Categories: News, US, CDER, Advertising and Promotion, Biologics and biotechnology, Drugs

Tags: DTC, Direct-to-Consumer Advertising, Study, Hearing, Elderly

FDA Drug Advertising Study Tracker By Alexander Gaffney, RAC - Published 12 January 2015

The US Food and Drug Administration (FDA) frequently studies consumer behavior, particularly as it relates to how members of the public (and medical professionals) understand pharmaceutical advertising. Our FDA Drug Advertising Study Tracker keeps tabs on these studies and explains what they're trying to accomplish in plain terms.

Categories: News, US, CDER, Advertising and Promotion, Biologics and biotechnology, Drugs, Labeling

Tags: Direct-to-Consumer Drug Advertising, DTC Drug Advertising, FDA Regulation of Drug Advertising, FDA Studies

FDA Considers Allowing Drug Companies to Drop Some Warnings in TV Commercials By Alexander Gaffney, RAC - Published 12 January 2015

The US Food and Drug Administration (FDA) has announced its plans to study whether consumers would benefit if direct-to-consumer television advertising contained a shorter list of major side effects instead of the now-lengthy list of nearly all of them.

Categories: News, US, CDER, Advertising and Promotion, Biologics and biotechnology, Drugs

Tags: DTC, DTC Advertising, Drug Risks, Fair Balance, Direct-to-Consumer, Study

DTC Broadcast Advertisements: The Evolution of Major Statements By Donato M. Forlenza, PharmD, MBA, and Nada A. Glavan, MPH - Published 25 September 2014

Direct-to-consumer (“DTC”) advertising has a long, robust regulatory history, mostly rooted in debates over the pros and cons of promoting a prescription drug directly to consumers. This article focuses on how the pharmaceutical industry communicates risk information in what can arguably be considered the most prominent and industry-preferred medium for healthcare advertising to consumers—broadcast advertising.

Categories: Features, US, Compliance, Drugs, Postmarket surveillance

Tags: direct-to-consumer advertising, history, FDAAA, enforcement actions

Do Distractions in Drug Ads Put Consumers at Risk? FDA Study to Find out By Alexander Gaffney, RAC - Published 12 September 2014

The US Food and Drug Administration (FDA) has received approval to go forward with a proposed study to study the effects of "distractions" in direct-to-consumer drug advertising, which it hypothesizes may reduce consumers' ability to remember risk information about a product.

Categories: News, US, CDER, Biologics and biotechnology, Drugs, Labeling

Tags: DTC Advertising, Direct-to-Consumer Drug Advertising, Pharmaceutical Advertising, Distractions in Drug Advertisements

FDA Plans Study on Corrective DTC Advertising By Alexander Gaffney - Published 28 February 2012

Categories: FDA

Tags: Direct-to-Consumer, Prescription, DTC, Latest News, pharmaceutical, advertising, study, drug